Cytomegalovirus Immunoglobulin Decreases the Risk of Cytomegalovirus Infection but not Disease After Pediatric Lung Transplantation
- 31 October 2009
- journal article
- research article
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 28 (10), 1050-1056
- https://doi.org/10.1016/j.healun.2009.04.032
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Registry of the International Society for Heart and Lung Transplantation: Eleventh Official Pediatric Lung and Heart/Lung Transplantation Report—2008The Journal of Heart and Lung Transplantation, 2008
- Ganciclovir for Cytomegalovirus: a Call for Indefinite Prophylaxis in Lung TransplantationThe Journal of Heart and Lung Transplantation, 2008
- Predictive factors for cytomegalovirus reactivation in cytomegalovirus‐seropositive kidney‐transplant patientsJournal of Medical Virology, 2008
- Ganciclovir/Valganciclovir Prophylaxis Decreases Cytomegalovirus-Related Events and Bronchiolitis Obliterans Syndrome after Lung TransplantationClinical Infectious Diseases, 2008
- CMV‐hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta‐analysisClinical Transplantation, 2007
- Combined CMV Prophylaxis Improves Outcome and Reduces the Risk for Bronchiolitis Obliterans Syndrome (BOS) after Lung TransplantationTransplantation, 2006
- Cytomegalovirus Prophylaxis and Graft Outcome in Solid Organ Transplantation: A Collaborative Transplant Study ReportAmerican Journal of Transplantation, 2004
- Cytomegalovirus viremia associated with death or retransplantation in pediatric lung-transplant recipientsTransplantation, 2003
- Definitions of Cytomegalovirus Infection and Disease in Transplant RecipientsClinical Infectious Diseases, 2002
- Infectious complications in heart-lung transplantation. Analysis of 200 episodesArchives of Internal Medicine, 1993